Iovance Biotherapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND IOVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

72,101

Value ($000)

197

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	197	0.0%	72,101	12/31/2025
2025 Q3	11/3/2025	156	0.0%	72,101	9/30/2025
2025 Q2	10/8/2025	124	0.0%	72,101	6/30/2025
2025 Q1	10/8/2025	3,734	0.0%	1,121,417	3/31/2025
2024 Q4	10/8/2025	8,298	0.0%	1,121,417	12/31/2024
2024 Q3	10/8/2025	11,458	0.0%	1,220,257	9/30/2024
2024 Q2	10/8/2025	9,695	0.0%	1,208,867	6/30/2024
2024 Q1	10/8/2025	17,261	0.0%	1,164,734	3/31/2024
2023 Q4	10/8/2025	8,307	0.0%	1,021,824	12/31/2023
2023 Q3	10/8/2025	4,673	0.0%	1,026,965	9/30/2023
2023 Q2	10/8/2025	5,882	0.0%	835,494	6/30/2023
2023 Q1	10/8/2025	4,138	0.0%	677,309	3/31/2023
2022 Q4	10/8/2025	3,780	0.0%	591,523	12/31/2022
2022 Q3	11/8/2022	5,408	0.0%	564,495	9/30/2022
2022 Q2	8/4/2022	6,125	0.0%	554,825	6/30/2022
2022 Q1	7/1/2022	8,686	0.0%	521,689	3/31/2022
2021 Q4	2/2/2022	9,959	0.0%	521,689	12/31/2021
2021 Q3	11/2/2021	15,574	0.0%	631,553	9/30/2021
2021 Q2	8/2/2021	16,997	0.0%	653,231	6/30/2021
2021 Q1	5/11/2021	20,327	0.0%	642,032	3/31/2021
2020 Q4	2/8/2021	31,559	0.0%	680,151	12/31/2020
2020 Q3	11/5/2020	22,995	0.0%	698,510	9/30/2020
2020 Q2	8/7/2020	19,017	0.0%	692,794	6/30/2020
2020 Q1	5/6/2020	13,505	0.0%	451,141	3/31/2020
2019 Q4	2/5/2020	11,563	0.0%	417,739	12/31/2019